E-LIB Suche - Ergebnisse für: Skarbnik, A.

1

GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RE..:

Hutchings, M. ; Avigdor, A. ; Sureda, A....
Hematological Oncology. 41 (2023) S2 - p. 138-140 , 2023

Link: https://doi.org/10.1002/..

2

A MATCHING‐ADJUSTED INDIRECT COMPARISON OF THE EFFICACY AND..:

Ghia, P. ; Skarbnik, A. ; Miranda, M....
Hematological Oncology. 41 (2023) S2 - p. 742-743 , 2023

Link: https://doi.org/10.1002/..

3

P671: TREATMENT SEQUENCES AND OUTCOMES OF PATIENTS WITH CLL..:

Mato, A. R. ; Manzoor, B. S. ; Coombs, C. C....
HemaSphere. 6 (2022) - p. 569-570 , 2022

Link: https://doi.org/10.1097/..

4

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORA..:

Sharman, J. P. ; Egyed, M. ; Jurczak, W....
HemaSphere. 6 (2022) - p. 564-565 , 2022

Link: https://doi.org/10.1097/..

5

A PHASE 2 STUDY TO ASSESS THE SAFETY AND EFFICACY OF UMBRAL..:

Mato, A.R. ; Schuster, S.J. ; Lamanna, N....
Hematological Oncology. 37 (2019) S2 - p. 88-89 , 2019

Link: https://doi.org/10.1002/..

6

Lisocabtagene maraleucel in follicular lymphoma: the phase ..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

7

Activity of venetoclax in patients with relapsed or refract..:

Kater, Arnon P ; Arslan, Önder ; Demirkan, Fatih...
The Lancet Oncology. 25 (2024) 4 - p. 463-473 , 2024

Link: https://doi.org/10.1016/..

8

Hypertension treatment for patients receiving ibrutinib: a ..:

Samples, Laura ; Voutsinas, Jenna ; Fakhri, Bita...
Blood Advances. 8 (2024) 9 - p. 2085-2093 , 2024

Link: https://doi.org/10.1182/..

9

Author Correction: Lisocabtagene maraleucel in follicular l..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

10

An indirect comparison of acalabrutinib with and without ob..:

Kittai, Adam S. ; Allan, John N. ; James, Dan...
Blood Advances. 8 (2024) 11 - p. 2861-2869 , 2024

Link: https://doi.org/10.1182/..

11

A matching‐adjusted indirect comparison of acalabrutinib ve..:

Kittai, Adam S. ; Skarbnik, Alan ; Miranda, Miguel...
American Journal of Hematology. 98 (2023) 12 - p. , 2023

Link: https://doi.org/10.1002/..

12

P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CH..:

Lansigan, Frederick ; A. Eyre, Toby ; Ghosh, Nilanjan...
HemaSphere. 7 (2023) S3 - p. e6855326 , 2023

Link: https://doi.org/10.1097/..

13

P642: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICA..:

Skarbnik, Alan ; Kittai, Adam ; Miranda, Miguel...
HemaSphere. 7 (2023) S3 - p. e4236347 , 2023

Link: https://doi.org/10.1097/..

14

P647: RACIAL DISPARITIES IN REAL-WORLD TREATMENT PATTERNS A..:

Rhodes, Joanna ; Shadman, Mazyar ; Lamanna, Nicole...
HemaSphere. 7 (2023) S3 - p. e96103aa , 2023

Link: https://doi.org/10.1097/..

15

Outcomes among adult recipients of CD19 CAR T-cell therapy ..:

Samples, Laura ; Sadrzadeh, Hossein ; Frigault, Matthew...
International Journal of Cancer Care and Delivery. 3 (2023) Supplement 2 - p. , 2023

Link: https://doi.org/10.53876..